The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 19, 2015

Filed:

May. 16, 2013
Applicant:

Asthmatx, Inc., Sunnyvale, CA (US);

Inventors:

Christopher J. Danek, San Carlos, CA (US);

Michael Biggs, San Francisco, CA (US);

Keith M. Burger, San Francisco, CA (US);

Bryan Loomas, Los Gatos, CA (US);

Thomas Keast, Mountain View, CA (US);

Dave Haugaard, San Jose, CA (US);

Assignee:

Asthmatx, Inc., Sunnyvale, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61N 5/00 (2006.01); A61N 1/06 (2006.01); A61B 18/08 (2006.01); A61B 17/00 (2006.01); A61B 18/00 (2006.01); A61B 18/04 (2006.01); A61B 19/00 (2006.01);
U.S. Cl.
CPC ...
A61N 5/00 (2013.01); A61B 18/08 (2013.01); A61B 18/1477 (2013.01); A61B 18/1492 (2013.01); A61B 2017/00084 (2013.01); A61B 2017/00123 (2013.01); A61B 2018/00214 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00267 (2013.01); A61B 2018/00541 (2013.01); A61B 2018/00982 (2013.01); A61B 2018/046 (2013.01); A61B 2019/5217 (2013.01); A61N 1/06 (2013.01);
Abstract

This relates to treating reversible chronic obstructive pulmonary disease, and more particularly, to exchanging energy with airway tissue such as that found in human lungs. This exchange of energy reduces the ability of the airways to constrict, reduces the resistance within the airway to the flow of air through the airway, reduces mucus plugging of the airways, and/or increases the airway diameter. This energy exchange also may reduce the ability of the lung to produce at least one of the symptoms of reversible obstructive pulmonary disease.


Find Patent Forward Citations

Loading…